A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants.

Abstract

Mortality in infant HCM is much lower than previously reported and resolution is more frequent. This may reflect increased detection of less severe forms in addition to the success of aggressive medical management including beta blockade.